Trials / Completed
CompletedNCT02477605
Clinical Comparison of 27+® and 23-gauge ULTRAVIT® 7500 Cpm Vitrectomy Outcomes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 137 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the treatment day change between immediate postoperative and immediate preoperative intraocular pressure (IOP) between 27-gauge and 23-gauge vitrectomy instruments.
Detailed description
Required follow-up for this study is 3 months post treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CONSTELLATION® 27-gauge Combined Surgical Pak | Sterile single-use supplies necessary to perform 1 vitrectomy surgery: 1 ULTRAVIT® 27-gauge 7500 cuts per minute (cpm) vitrectomy probe and a 27-gauge EDGEPLUS® Valved Entry System comprised of 3 trocar/cannulas and related accessories. |
| DEVICE | CONSTELLATION® 23-gauge Combined Surgical Pak | Sterile single-use supplies necessary to perform 1 vitrectomy surgery: 1 ULTRAVIT® 23-gauge 7500 cuts per minute (cpm) vitrectomy probe and a 23-gauge EDGEPLUS® trocar/cannula set comprising of 3 trocars/cannulas and related accessories. |
| PROCEDURE | Vitrectomy surgery | Microincisional pars plana vitrectomy (PPV) surgery for the treatment of various vitreoretinal diseases ranging from simple to advanced cases |
Timeline
- Start date
- 2015-07-16
- Primary completion
- 2016-06-01
- Completion
- 2016-08-31
- First posted
- 2015-06-23
- Last updated
- 2018-07-02
- Results posted
- 2017-07-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02477605. Inclusion in this directory is not an endorsement.